Protocol to create phenotypic primary human hepatocyte cultures using the RASTRUM 3D cell model platform

Authors:
Christine Yee , Yik Lung Chan , Robert Utama , Marie Besnier , Martin Engel , Lisa Belfiore 
In:
Source: STAR Protoc
Publication Date: (2024)
Issue: 5: 103234
Research Area:
Gastroenterology
Toxicology
Drug Discovery
Cells used in publication:
Hepatocyte, human
Species: human
Tissue Origin: liver
Experiment

This protocol was optimized to generate PHH 3D cell models using cryopreserved primary human hepatocytes (Lonza, #HUCPI), but cell responses are donor-dependent and can vary with disease state. The starting cell number per vial, expected viability and attachment rate in 2D can vary between donors. Printing PHH in RASTRUM Matrix may require optimization of matrix composition, cell density and drug dosing depending on the specific PHH source used.

Abstract

To improve human hepatotoxicity prediction, in vitro liver cell models replicating hepatocyte function, drug metabolism, and toxicity are required. Here, we present a protocol for creating 3D primary human hepatocyte (PHH) cell models using the RASTRUM Platform. We describe the process for PHH model generation; procedures for characterizing the PHH model, including viability, albumin production, and CYP450 inducibility; and drug treatment using acetaminophen and troglitazone. This protocol has applications in upscaling phenotypic hepatotoxicity applications.